Stocks Erase Losses from Monday's Sell-off, Dow Components Join the Earnings Parade, Netflix's Subscriber Growth Slowdown, United Sees Profitablilty Ahead, J&J's COVID Vaccine Under Scrutiny, and Chipotle's Results Heat Up the Stock
Listen now
Description
Jim Cramer and David Faber took an in-depth look at a busy day for the markets with a slew of earnings reports in the mix -- as stocks recouped all of their losses from Monday's sell-off. Dow components Coca-Cola, Johnson & Johnson and Verizon all beating analyst expectations with their quarterly results, Netflix falling amid concerns about a slowdown in subscriber growth, and Chipotle shares up sharply on earnings, revenue and sales as indoor dining continues to rebound. The anchors reacted to what United Airlines CEO Scott Kirby told CNBC about the carrier's outlook: He's "confident" United will return to profitability in the third quarter. They also highlighted Capitol Hill's "bipartisan bailout" of the airlines during the pandemic, and the lessons to be learned as lawmakers negotiate a bipartisan infrastructure bill. Cramer sounds off about a new study that claims J&J's COVID vaccine is much less effective against the Delta and Lambda variants than against the original virus. Also in focus: Electric vehicle maker Lucid Motors and the Churchill Capital IV SPAC scramble for shareholder approval votes ahead of a key deadline, billionaire investor Leon Cooperman's bullish take on big tech and FAANG, AMC Entertainment CEO Adam Aron taking on the additional role of Chairman and what it could mean for the stock, what's ahead for GameStop in wake of Netflix's foray into video games, the stocks that are benefiting from investors pushing aside worries about the Delta Variant, and JPMorgan Chase awards Jamie Dimon a bonus aimed at keeping him as Chairman & CEO for several more years.
More Episodes
Carl Quintanilla, Jim Cramer and David Faber reacted to shares of Tesla surging just days after falling to a 52-week low. The EV maker’s plans to produce "more affordable" vehicles overshadowed weaker-than-expected Q1 results. What should you do with the stock?  In an exclusive interview, Boeing...
Published 04/24/24
Published 04/24/24
Jim and Jeff discuss the comeback of this health-care stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer
Published 04/23/24